Scarica l'app Stockscreener
4.61
14.63%
-0.79
Dopo l'orario di chiusura:
3.80
-0.81
-17.57%
Precedente Chiudi:
$5.40
Aprire:
$5.4542
Volume 24 ore:
18,472
Relative Volume:
0.00
Capitalizzazione di mercato:
$5.10M
Reddito:
-
Utile/perdita netta:
$-15.42M
Rapporto P/E:
-2.5054
EPS:
-1.84
Flusso di cassa netto:
$-13.41M
1 W Prestazione:
-27.86%
1M Prestazione:
-36.85%
6M Prestazione:
+462.20%
1 anno Prestazione:
+217.93%
Intervallo 1D:
$4.46
$5.57
Intervallo di 1 settimana:
$4.46
$6.65
Portata 52W:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Nome
Indaptus Therapeutics Inc
Settore
Industria
Telefono
(646) 427-2727
Indirizzo
3 COLUMBUS CIRCLE, NEW YORK
Confronta INDP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
4.61 | 6.81M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Indaptus Therapeutics Inc Borsa (INDP) Ultime notizie
Indaptus Therapeutics provides clinical update - MarketScreener
Indaptus reports partial response in cancer patient with Decoy20 - Investing.com
Indaptus Therapeutics Provides Clinical Update - GlobeNewswire
Cancer Drug Shrinks Liver Metastases: Indaptus's Decoy20 Shows Promise in Urothelial Cancer Patient Study - Stock Titan
Does Indaptus Therapeutics Inc. have a sustainable dividend2025 Trade Ideas & Free Fast Gain Swing Trade Alerts - khodrobank.com
Will Indaptus Therapeutics Inc. stock recover after recent dropProduct Launch & Technical Buy Zone Confirmation - Newser
Signal strength of Indaptus Therapeutics Inc. stock in tech scannersJuly 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
Is Indaptus Therapeutics Inc. meeting your algorithmic filter criteriaMarket Performance Recap & High Accuracy Swing Entry Alerts - Newser
What are Indaptus Therapeutics Inc.’s earnings expectationsJuly 2025 Action & Long-Term Investment Growth Plans - khodrobank.com
How to use Fibonacci retracement on Indaptus Therapeutics Inc.Stop Loss & Capital Protection Trade Alerts - Newser
Order flow analysis tools used on Indaptus Therapeutics Inc.Earnings Risk Report & Consistent Growth Equity Picks - Newser
Indaptus Therapeutics Inc. stock momentum explainedJuly 2025 Closing Moves & AI Forecasted Stock Moves - Newser
News impact scoring models applied to Indaptus Therapeutics Inc.Market Weekly Review & Fast Entry High Yield Stock Tips - Newser
Will Indaptus Therapeutics Inc. stock go up soonPortfolio Profit Report & Reliable Price Breakout Alerts - Newser
Published on: 2025-09-03 05:54:24 - Newser
Applying big data sentiment scoring on Indaptus Therapeutics Inc.Swing Trade & Free Reliable Trade Execution Plans - Newser
Indaptus Therapeutics Inc. stock trend outlook and recovery path2025 Big Picture & Accurate Entry and Exit Point Alerts - Newser
What MACD signals say about Indaptus Therapeutics Inc.July 2025 News Drivers & High Accuracy Investment Signals - Newser
Is Indaptus Therapeutics Inc. forming a bottoming base2025 Momentum Check & Real-Time Market Trend Scan - Newser
Evaluating Indaptus Therapeutics Inc. with trendline analysis2025 Market Sentiment & Daily Stock Trend Reports - Newser
Can Indaptus Therapeutics Inc. sustain its profitabilityJobs Report & Weekly Setup with High ROI Potential - khodrobank.com
Real time alert setup for Indaptus Therapeutics Inc. performanceJuly 2025 Sentiment & Technical Confirmation Alerts - Newser
Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference - GlobeNewswire
Biotech Indaptus Therapeutics Joins Major Healthcare Conference: CEO to Present Latest Developments - Stock Titan
Comparing Indaptus Therapeutics Inc. in custom built stock radarsEarnings Summary Report & Free Community Consensus Stock Picks - Newser
Short interest data insights for Indaptus Therapeutics Inc.Sell Signal & Real-Time Buy Zone Alerts - Newser
Analyzing Indaptus Therapeutics Inc. with multi timeframe chartsWeekly Loss Report & Low Drawdown Investment Ideas - Newser
Can Indaptus Therapeutics Inc. be recession proof2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - khodrobank.com
Can Indaptus Therapeutics Inc. keep up with sector leadersDip Buying & Daily Technical Forecast Reports - khodrobank.com
Will Indaptus Therapeutics Inc. outperform the market in YEAR2025 Price Targets & Growth Focused Investment Plans - khodrobank.com
Using RSI to spot recovery in Indaptus Therapeutics Inc.Day Trade & AI Forecasted Entry/Exit Points - Newser
Is Indaptus Therapeutics Inc. stock influenced by commodity prices2025 Market Overview & Verified Momentum Stock Alerts - khodrobank.com
Breakout Traders Target Indaptus Therapeutics Inc. on Recovery Setup getLinesFromResByArray error: size == 0 - kangso.co.kr
Why Indaptus Therapeutics Inc. stock attracts strong analyst attention2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
What technical models suggest about Indaptus Therapeutics Inc.’s comebackTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
Combining price and volume data for Indaptus Therapeutics Inc.Weekly Market Report & Daily Chart Pattern Signals - Newser
Indaptus Therapeutics Inc.’s Beta Climbs After Market Volatility getLinesFromResByArray error: size == 0 - thegnnews.com
Is Indaptus Therapeutics Inc. forming higher highs and higher lows getLinesFromResByArray error: size == 0 - sisain.net
Published on: 2025-08-31 00:20:25 - beatles.ru
Indaptus Therapeutics Inc. stock trendline breakdownExit Point & Expert Approved Momentum Ideas - Newser
Indaptus Therapeutics Inc Azioni (INDP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):